This highlights a critical need for robust regulatory compliance and data management solutions to prevent future delays.
Filing excerpt
For mRNA-1010, in response to a prior Refusal-to-File letter, we engaged with the U.S. Food and Drug Administration (FDA) in a Type A meeting and submitted an amended biologics license application (BLA) outlining a revised regulatory pathway based on age...
What this signalsFilings often name leadership changes, deals and spending plans.
Regions named
sec-10kcomplianceBurdenGet every 10-K signal for Moderna and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Moderna this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/f273aa8f-a689-4014-9180-2d506ad8e5bc returns this record as JSON. POST /v1/companies/enrich returns every signal for modernatx.com.
{
"signal_id": "f273aa8f-a689-4014-9180-2d506ad8e5bc",
"signal_type": "sec-10k",
"signal_subtype": "complianceBurden",
"detected_at": "2026-02-24T09:33:59.024+00:00",
"company": {
"name": "Moderna",
"domain": "modernatx.com"
},
"data": {
"detail": "The company experienced a significant regulatory setback, requiring them to engage in a Type A meeting with the FDA and submit an amended application with a revised strategy. This highlights a critical need for robust regulatory compliance and data management solutions to prevent future delays.",
"metrics": {
"timeframe": "current_year"
},
"summary": "Moderna faced FDA 'Refusal-to-File' letter for flu vaccine candidate mRNA-1010",
"excerpts": "For mRNA-1010, in response to a prior Refusal-to-File letter, we engaged with the U.S. Food and Drug Administration (FDA) in a Type A meeting and submitted an amended biologics license application (BLA) outlining a revised regulatory pathway based on age...",
"relevance": 0.8,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285226000033/mrna-20251231.htm",
"filing_date": "2026-02-20",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "GRC tools needed",
"signal_category": "risk",
"regions_mentioned": [
"United States"
]
}
}
curl https://signals.autobound.ai/v1/signals/f273aa8f-a689-4014-9180-2d506ad8e5bc \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"modernatx.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.